Biodegradable iron oxide nanoparticles for intraoperative parathyroid gland imaging in thyroidectomy

Abstract Parathyroid gland (PG) injury is the most common complication of thyroidectomy owing to the lack of approaches for surgeons to effectively distinguish PGs from surrounding thyroid glands (TGs) in the operation room. Herein, we report the development of biodegradable iron oxide nanoparticles (IONPs) as a promising contrast agent candidate for intraoperative PG visualization. We elucidated that locally administrated dark-colored IONPs readily diffuse in TGs but cannot infiltrate tissue-dense PGs, yielding a distinguishable contrast enhancement between PGs and TGs by naked eye observation. We performed unbiased and quantitative in vivo screenings to optimize particle size and concentration of IONPs for PG/TG contrast enhancement. Moreover, in vivo applications of IONPs via the local administration route demonstrate no adverse toxicities and can be biodegraded in the thyroid microenvironment within 3 months. To our knowledge, these promising findings provide the first in vivo evidence that IONPs can serve as a safe, biodegradable, and effective contrast agent candidate for improving PG visualization in thyroidectomy.

[1]  A. Jemal,et al.  Cancer Statistics, 2021 , 2021, CA: a cancer journal for clinicians.

[2]  I. S. Raja,et al.  A critical review on genotoxicity potential of low dimensional nanomaterials. , 2020, Journal of hazardous materials.

[3]  Juyoung Yoon,et al.  Activity-Based NIR Enzyme Fluorescent Probes for the Diagnosis of Tumors and Image-Guided Surgery. , 2020, Angewandte Chemie.

[4]  Adam Frtús,et al.  Analyzing the mechanisms of iron oxide nanoparticles interactions with cells: A road from failure to success in clinical applications. , 2020, Journal of controlled release : official journal of the Controlled Release Society.

[5]  K. Kuča,et al.  The Puzzling Potential of Carbon Nanomaterials: General Properties, Application, and Toxicity , 2020, Nanomaterials.

[6]  Lifeng Liu,et al.  Do carbon nanoparticles really improve thyroid cancer surgery? A retrospective analysis of real-world data , 2020, World Journal of Surgical Oncology.

[7]  Lin-bo Zhu,et al.  Infiltration of nanocarbon suspension into the tracheal cavity during surgical treatment of papillary thyroid carcinoma: a case report , 2020, The Journal of international medical research.

[8]  Pieterjan Debie,et al.  Latest developments in molecular tracers for fluorescence image-guided cancer surgery. , 2019, The Lancet. Oncology.

[9]  Ying Liu,et al.  Long-term pulmonary exposure to multi-walled carbon nanotubes promotes breast cancer metastatic cascades , 2019, Nature Nanotechnology.

[10]  Seyed Mohammadali Dadfar,et al.  Iron oxide nanoparticles: Diagnostic, therapeutic and theranostic applications , 2019, Advanced drug delivery reviews.

[11]  J. Sosa,et al.  Thyroid surgery for differentiated thyroid cancer — recent advances and future directions , 2018, Nature Reviews Endocrinology.

[12]  Peisong Wang,et al.  Short and Long-Term Potential Role of Carbon Nanoparticles in Total Thyroidectomy with Central Lymph Node Dissection , 2018, Scientific Reports.

[13]  Yang Li,et al.  Optical molecular imaging for tumor detection and image-guided surgery. , 2018, Biomaterials.

[14]  Kheireddine El-Boubbou Magnetic iron oxide nanoparticles as drug carriers: clinical relevance. , 2018, Nanomedicine.

[15]  Lucía Gutiérrez,et al.  Effect of Surface Chemistry and Associated Protein Corona on the Long-Term Biodegradation of Iron Oxide Nanoparticles In Vivo. , 2018, ACS applied materials & interfaces.

[16]  F. Marini,et al.  Raman Spectroscopy Applied to Parathyroid Tissues: A New Diagnostic Tool to Discriminate Normal Tissue from Adenoma. , 2018, Analytical chemistry.

[17]  D. Chadwick Hypocalcaemia and permanent hypoparathyroidism after total/bilateral thyroidectomy in the BAETS Registry. , 2017, Gland surgery.

[18]  B. Lang,et al.  To identify or not to identify parathyroid glands during total thyroidectomy. , 2017, Gland surgery.

[19]  A. Shuman,et al.  Thyroid cancer surgery guidelines in an era of de-escalation. , 2017, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[20]  J. Fagin,et al.  Biologic and Clinical Perspectives on Thyroid Cancer. , 2016, The New England journal of medicine.

[21]  L. Motte,et al.  Massive Intracellular Biodegradation of Iron Oxide Nanoparticles Evidenced Magnetically at Single-Endosome and Tissue Levels. , 2016, ACS nano.

[22]  Liying Wang,et al.  Carcinogenic Potential of High Aspect Ratio Carbon Nanomaterials. , 2016, Environmental science. Nano.

[23]  P. Kalra,et al.  Efficacy and safety of iron isomaltoside (Monofer®) in the management of patients with iron deficiency anemia , 2016, International journal of nephrology and renovascular disease.

[24]  Michael Iv,et al.  Clinical applications of iron oxide nanoparticles for magnetic resonance imaging of brain tumors. , 2015, Nanomedicine.

[25]  Natalia Dworak,et al.  Genotoxic and mutagenic activity of diamond nanoparticles in human peripheral lymphocytes in vitro , 2014 .

[26]  W. Reinisch,et al.  A Randomized, Open-Label, Non-Inferiority Study of Intravenous Iron Isomaltoside 1,000 (Monofer) Compared With Oral Iron for Treatment of Anemia in IBD (PROCEED) , 2013, The American Journal of Gastroenterology.

[27]  U. Kolb,et al.  A comparative study of the physicochemical properties of iron isomaltoside 1000 (Monofer), a new intravenous iron preparation and its clinical implications. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[28]  F. Gendron,et al.  Long term in vivo biotransformation of iron oxide nanoparticles. , 2011, Biomaterials.

[29]  Wei Xiong,et al.  DNA damage in embryonic stem cells caused by nanodiamonds. , 2011, ACS nano.

[30]  A. Vale,et al.  Dimercaptosuccinic acid (succimer; DMSA) in inorganic lead poisoning , 2009, Clinical toxicology.

[31]  E. Berber,et al.  Autofluorescence imaging of parathyroid glands: An assessment of potential indications. , 2019, Surgery.

[32]  P DESAIVE,et al.  [Thyroid cancer]. , 1951, Revue medicale de Liege.